A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

Abstract Background Batefenterol (BAT) is a bi-functional molecule with both muscarinic antagonist and β2-adrenoceptor agonist pharmacology. This Phase II, randomized, placebo-controlled, double-blind study evaluated the safety and tolerability of BAT 300 μg with fluticasone furoate (FF) 100 μg admi...

Full description

Bibliographic Details
Main Authors: Courtney Crim, Mark Gotfried, Selwyn Spangenthal, Michael Watkins, Amanda Emmett, Catriona Crawford, Charlotte Baidoo, Ramiro Castro-Santamaria
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Pulmonary Medicine
Subjects:
Bronchodilator
Bi-functional molecule
Triple therapy
Safety
Online Access:http://link.springer.com/article/10.1186/s12890-020-1153-7

Internet

http://link.springer.com/article/10.1186/s12890-020-1153-7

Similar Items